prednisone has been researched along with pci 32765 in 38 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 21 (55.26) | 24.3611 |
| 2020's | 17 (44.74) | 2.80 |
| Authors | Studies |
|---|---|
| Aoki, S | 1 |
| Zinzani, PL | 1 |
| Amorim, S; Balasubramanian, S; Bandyopadhyay, N; de Vries, R; Flinn, I; Fourneau, N; Friedberg, JW; Hellemans, P; Hivert, B; Morschhauser, F; Oki, Y; Smit, JW; Thieblemont, C; Vermeulen, J; Westin, J; Younes, A | 1 |
| Yamamoto, K | 1 |
| Bowen, D; Call, TG; Chanan-Khan, A; Conte, M; Ding, W; Hanson, CA; Kay, NE; Leis, JF; Nowakowski, GS; Parikh, SA; Schwager, SM; Shanafelt, TD; Slager, SL; Tsang, M | 1 |
| Adam, Z; Král, Z; Krejčí, M; Mayer, J; Pour, L; Pourová, E; Ševčíková, E; Ševčíková, S | 1 |
| Barańska-Rybak, W; Mital, A; Nowicki, R; Sobjanek, M; Sławińska, M; Wilkowska, A | 1 |
| Allen, J; Badillo, M; Lee, HJ; Ok, CY; Prabhu, V; Romaguera, JE; Sadimin, ET; Schalop, L; Schenkel, J; Tarapore, R; Wang, M; Zloza, A | 1 |
| Bohn, JP; Rudzki, J; Steurer, M; Stockhammer, G; Wanner, D | 1 |
| Gottlieb, T; Swan, CD | 1 |
| Till, BG | 1 |
| Anwer, F; Durer, C; Durer, S; Faridi, W; Fraz, MA; Ijaz, A; Khan, AY; Kumar, A; Malik, SU; Nasar, A; Qureshi, A; Tariq, MJ; Usman, M | 1 |
| Balasubramanian, S; Belada, D; Carey, J; Cheung, MC; Chiattone, CS; Dührsen, U; Gurion, R; Hong, X; Johnson, P; Jurczak, W; Leppä, S; Liu, G; Lopez-Hernandez, A; Patti, C; Rai, S; Samoilova, O; Sehn, LH; Shreeve, SM; Staudt, LM; Suh, C; Sun, S; Thieblemont, C; Turgut, M; Vermeulen, J; Wilson, W; Yeh, SP; Younes, A; Zhu, J; Zhuang, SH; Zinzani, PL | 1 |
| Gourd, E | 1 |
| Leonard, JP | 1 |
| Badros, A; Bukhari, A; Dahiya, S; El Chaer, F; Hardy, N; Hutnick, E; Kocoglu, MH; Koka, R; Lee, ST; Rapoport, AP; Ruehle, K; Shanholtz, C; Singh, Z; Yared, J | 1 |
| Staudt, L; Wilson, WH; Younes, A | 1 |
| Lucijanić, M; Miketic, T; Skelin, M | 1 |
| Au-Yeung, R; Kwong, YL; Leung, RYY; Pang, A | 1 |
| Arias-Martínez, A; Carriles, C; Menárguez-Blanc, R; Ordóñez-Fernández, L; Rosado-María, MC | 1 |
| Burudpakdee, C; Kabadi, SM; Near, A; Wada, K | 1 |
| Al Tourah, AJ; Bruyere, H; Dueck, G; Galbraith, P; Gerrie, AS; Hardy, E; Hrynchak, M; Huang, SJ; Noble, MC; Ramadan, KM; Sehn, L; Toze, CL; Tsang, P; Tucker, T; Young, S | 1 |
| Choi, YS; Do, YR; Kim, MK; Kim, SJ; Kim, WS; Ko, YH; Koh, Y; Lee, GW; Mun, YC; Suh, C; Yang, DH; Yoon, DH; Yoon, SE | 1 |
| Chen, Z; Li, Y; Tian, C | 1 |
| Breland, UM; Marvyin, K; Tjønnfjord, EB; Tjønnfjord, GE | 1 |
| Aquino, R; Balasubramanian, S; Chaturvedi, S; Davis, C; de Jong, J; Fourneau, N; Oki, Y; Schaffer, M; Younes, A | 1 |
| Byfield, SD; Kabadi, SM; LE, L; Olufade, T | 1 |
| Burningham, Z; Chien, HC; Halwani, AS; Li, CY; Morreall, D; Passey, DG; Patil, V; Rasmussen, KM; Sauer, BC; Yong, CM | 1 |
| Beaupre, D; Chhabra, S; de Vos, S; Huang, DW; Kimball, AS; Kwei, K; Neuenburg, JK; Phillips, T; Ping, J; Popplewell, L; Staudt, LM; Wilson, WH; Wright, G | 1 |
| Balasubramanian, S; Carey, J; Gerecitano, J; Hodkinson, B; Johnson, P; Major, C; Schaffer, M; Sehn, LH; Shreeve, SM; Staudt, LM; Sun, S; Vermeulen, J; Wang, S; Wilson, W; Zinzani, PL | 1 |
| Castillo, JJ; Flynn, CA; LaMacchia, J; Pozdnyakova, O; Sarosiek, S; Treon, SP | 1 |
| Bittner, A; Bogner, C; Bullinger, L; Denker, S; Dürig, J; Frick, M; Hoffmann, J; Hüttmann, A; Janz, M; Kase, J; Keller, U; Krohn, U; Marks, R; Mathas, S; Na, IK; Schmitt, CA; Trenker, C | 1 |
| Balasubramanian, S; Fan, Y; Hodkinson, B; Huang, DW; Shreeve, M; Staudt, LM; Vermeulen, J; Wilson, WH; Wright, GW | 1 |
| Abu Zaid, M; Albring, JC; Bruno, B; Bulabois, CE; Cooney, JP; Flowers, M; Greinix, H; Jacobsohn, D; Ko, BS; Lee, Y; Miklos, DB; Mokatrin, A; Skarbnik, AP; Socie, G; Sohn, SK; Styles, L; Teshima, T; Wahlstrom, JT; Waller, EK; Yakoub-Agha, I; Yared, J | 1 |
| Balasubramanian, S; Hodkinson, B; Johnson, PWM; Sehn, LH; Shreeve, SM; Srinivasan, S; Steele, AJ; Sun, S; Vermeulen, J; Wilson, WH | 1 |
| Sheng, Z; Wang, L | 1 |
| Chu, X; Liu, X; Sui, X; Wang, L; Wu, S; Yu, G | 1 |
| Caces, DB; Curtis, M; Danielewicz, I; Freeman, J; García-Sancho, AM; Glazunova, V; Grigg, A; Henninger, T; Hess, G; Hou, JZ; Janssens, A; Kim, SJ; Masliak, Z; McKay, P; Merli, F; Munakata, W; Nagai, H; Nastoupil, LJ; Özcan, M; Pavlovsky, MA; Preis, M; Qin, R; Rowe, M; Salles, G; Tamegnon, M; Thieblemont, C; Wang, T | 1 |
7 review(s) available for prednisone and pci 32765
| Article | Year |
|---|---|
[Chronic lymphocytic leukemia].
Topics: Adenine; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Cyclophosphamide; Doxorubicin; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Nitrogen Mustard Compounds; Piperidines; Practice Guidelines as Topic; Prednisone; Pyrazoles; Pyrimidines; Rituximab; Vidarabine; Vincristine | 2014 |
[Standard of care and new drugs for diffuse large B-cell lymphoma].
Topics: Adenine; Animals; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Drug Discovery; Epigenesis, Genetic; Humans; Lenalidomide; Lymphoma, Large B-Cell, Diffuse; Mice; Molecular Targeted Therapy; Piperidines; Prednisolone; Prednisone; Pyrazoles; Pyrimidines; Radiotherapy, Adjuvant; Rituximab; Thalidomide; Vincristine; Vindesine | 2014 |
[Changes in the prognosis and treatment of Waldenström macroglobulinemia. Literature overview and own experience].
Topics: Adenine; Anemia; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Cyclophosphamide; Dexamethasone; Doxorubicin; Humans; Immunoglobulin M; Lenalidomide; Lymphatic Diseases; Neoplasm Recurrence, Local; Piperidines; Prednisone; Prognosis; Pyrazoles; Pyrimidines; Remission Induction; Rituximab; Splenomegaly; Thalidomide; Thrombocytopenia; Vincristine; Waldenstrom Macroglobulinemia | 2016 |
Topics: Adenine; Aged; Amphotericin B; Antibodies, Monoclonal, Murine-Derived; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Cryptococcosis; Cryptococcus neoformans; Cyclophosphamide; Doxorubicin; Empyema, Pleural; Fluconazole; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Piperidines; Prednisone; Pyrazoles; Pyrimidines; Rituximab; Vincristine | 2018 |
Maintenance Therapy in Diffuse Large B Cell Lymphoma and Mantle Cell Lymphoma.
Topics: Adenine; Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bortezomib; Cyclophosphamide; Doxorubicin; Everolimus; Female; Hematopoietic Stem Cell Transplantation; Humans; Lenalidomide; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell; Maintenance Chemotherapy; Male; Middle Aged; Neoplasm Recurrence, Local; Piperidines; Prednisone; Pyrazoles; Pyrimidines; Rituximab; Vincristine; Young Adult | 2018 |
Treating Diffuse Large B Cell Lymphoma in the Very Old or Frail Patients.
Topics: Adenine; Aged; Aged, 80 and over; Anthracyclines; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Brentuximab Vedotin; Cyclophosphamide; Doxorubicin; Female; Frail Elderly; Humans; Immunoconjugates; Immunotherapy; Lenalidomide; Lymphoma, Large B-Cell, Diffuse; Male; Piperidines; Prednisone; Pyrazoles; Pyrimidines; Rituximab; Vincristine | 2018 |
Superiority of ibrutinib plus bendamustine and rituximab in newly diagnosed patients with mantle-cell lymphoma ineligible for intensive therapy: A network meta-analysis.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, Mantle-Cell; Network Meta-Analysis; Prednisone; Prospective Studies; Randomized Controlled Trials as Topic; Rituximab; Vincristine | 2023 |
8 trial(s) available for prednisone and pci 32765
| Article | Year |
|---|---|
Combination of ibrutinib with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) for treatment-naive patients with CD20-positive B-cell non-Hodgkin lymphoma: a non-randomised, phase 1b study.
Topics: Adenine; Administration, Oral; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Maximum Tolerated Dose; Middle Aged; Non-Randomized Controlled Trials as Topic; Piperidines; Prednisone; Prognosis; Pyrazoles; Pyrimidines; Rituximab; Severity of Illness Index; Survival Rate; Treatment Outcome; Vincristine; Young Adult | 2014 |
Randomized Phase III Trial of Ibrutinib and Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Non-Germinal Center B-Cell Diffuse Large B-Cell Lymphoma.
Topics: Adenine; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Double-Blind Method; Doxorubicin; Female; Humans; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Piperidines; Placebos; Prednisone; Progression-Free Survival; Pyrazoles; Pyrimidines; Rituximab; Survival Rate; Vincristine; Young Adult | 2019 |
A phase II study of ibrutinib in combination with rituximab-cyclophosphamide-doxorubicin hydrochloride-vincristine sulfate-prednisone therapy in Epstein-Barr virus-positive, diffuse large B cell lymphoma (54179060LYM2003: IVORY study): results of the fina
Topics: Adenine; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Case-Control Studies; Cyclophosphamide; Doxorubicin; Epstein-Barr Virus Infections; Female; Follow-Up Studies; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Piperidines; Prednisone; Prospective Studies; Pyrazoles; Pyrimidines; Rituximab; Vincristine | 2020 |
Activity of ibrutinib plus R-CHOP in diffuse large B-cell lymphoma: Response, pharmacodynamic, and biomarker analyses of a phase Ib study.
Topics: Adenine; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Piperidines; Prednisone; Prognosis; Rituximab; Vincristine | 2020 |
Phase 1b/2 study of ibrutinib and lenalidomide with dose-adjusted EPOCH-R in patients with relapsed/refractory diffuse large B-cell lymphoma.
Topics: Adenine; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Lenalidomide; Lymphoma, Large B-Cell, Diffuse; Piperidines; Prednisone; Treatment Outcome; Vincristine | 2021 |
Comparison of immunohistochemistry and gene expression profiling subtyping for diffuse large B-cell lymphoma in the phase III clinical trial of R-CHOP ± ibrutinib.
Topics: Adenine; Adult; Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Cyclophosphamide; Doxorubicin; Gene Expression Profiling; Germinal Center; Humans; Immunohistochemistry; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Neoplastic Stem Cells; Piperidines; Prednisone; Prognosis; Progression-Free Survival; Rituximab; Treatment Outcome; Vincristine | 2021 |
Ibrutinib for First-Line Treatment of Chronic Graft-Versus-Host Disease: Results From the Randomized Phase III iNTEGRATE Study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bronchiolitis Obliterans Syndrome; Child; Double-Blind Method; Humans; Piperidines; Prednisone; Progression-Free Survival | 2023 |
Phase 3 SELENE study: ibrutinib plus BR/R-CHOP in previously treated patients with follicular or marginal zone lymphoma.
Topics: Adult; Bendamustine Hydrochloride; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Follicular; Piperidines; Prednisone; Rituximab; Vincristine | 2023 |
23 other study(ies) available for prednisone and pci 32765
| Article | Year |
|---|---|
A treatment for activated B-cell-like DLBCL?
Topics: Adenine; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Piperidines; Prednisone; Pyrazoles; Pyrimidines; Rituximab; Vincristine | 2014 |
The efficacy of ibrutinib in the treatment of Richter syndrome.
Topics: Adenine; Agammaglobulinaemia Tyrosine Kinase; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Piperidines; Prednisone; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrazoles; Pyrimidines; Rituximab; Syndrome; Vincristine | 2015 |
Ibrutinib-induced pyoderma gangrenosum.
Topics: Adenine; Cyclosporine; Drug Therapy, Combination; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Piperidines; Prednisone; Pyoderma Gangrenosum; Pyrazoles; Pyrimidines | 2016 |
Integrated stress response and immune cell infiltration in an ibrutinib-refractory mantle cell lymphoma patient following ONC201 treatment.
Topics: Adenine; Agammaglobulinaemia Tyrosine Kinase; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Cyclophosphamide; Dopamine D2 Receptor Antagonists; Doxorubicin; Drug Resistance, Neoplasm; Drug Substitution; Heterocyclic Compounds, 4 or More Rings; Humans; Imidazoles; Lymphocytes, Tumor-Infiltrating; Lymphoma, Mantle-Cell; Male; Molecular Targeted Therapy; Neoplasm Proteins; Oligopeptides; Piperidines; Prednisone; Protein Kinase Inhibitors; Pyrazoles; Pyridines; Pyrimidines; Rituximab; Stress, Physiological; Vincristine | 2019 |
Autoimmune myelitis in a CLL patient undergoing treatment with ibrutinib.
Topics: Adenine; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Autoimmune Diseases; Cyclophosphamide; Doxorubicin; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Myelitis; Piperidines; Prednisone; Pyrazoles; Pyrimidines; Rituximab; Vincristine | 2019 |
Promising new combination therapy for non-GCB DLBCL.
Topics: Adenine; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials, Phase III as Topic; Cyclophosphamide; Disease Progression; Doxorubicin; Humans; Lymphoma, Large B-Cell, Diffuse; Multicenter Studies as Topic; Piperidines; Prednisone; Progression-Free Survival; Pyrazoles; Pyrimidines; Randomized Controlled Trials as Topic; Rituximab; Vincristine | 2019 |
De-Cell-eration in Therapy for Diffuse Large B-Cell Lymphoma.
Topics: Adenine; B-Lymphocytes; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, Large B-Cell, Diffuse; Piperidines; Prednisone; Pyrazoles; Pyrimidines; Rituximab; Vincristine | 2019 |
Rapid relapse of large B-cell lymphoma after CD19 directed CAR-T-cell therapy due to CD-19 antigen loss.
Topics: Adenine; Antibodies, Monoclonal, Humanized; Antigens, CD19; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Biological Products; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Fatal Outcome; Female; Humans; Immunotherapy, Adoptive; Isoindoles; Lymphocyte Depletion; Lymphoma, B-Cell; Lymphoma, Follicular; Male; Middle Aged; Neoplasms, Multiple Primary; Piperidines; Prednisone; Pyrazoles; Pyrimidines; Recurrence; Salvage Therapy; Vincristine | 2019 |
Reply to M. Skelin et al.
Topics: Adenine; B-Lymphocytes; Cyclophosphamide; Doxorubicin; Humans; Piperidines; Prednisone; Pyrazoles; Pyrimidines; Rituximab; Vincristine | 2019 |
Above What Age Should Ibrutinib Not Be Given With R-CHOP to Patients With Non-GBC DLBCL?
Topics: Adenine; B-Lymphocytes; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, Large B-Cell, Diffuse; Piperidines; Prednisone; Pyrazoles; Pyrimidines; Rituximab; Vincristine | 2019 |
Addictive response of primary cutaneous diffuse large B cell lymphoma leg type to low-dose ibrutinib.
Topics: Adenine; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Humans; Leg; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Piperidines; Prednisone; Pyrazoles; Pyrimidines; Rituximab; Skin Neoplasms; Vincristine | 2019 |
Autoimmune hemolytic anemia, adverse event to venetoclax.
Topics: Adenine; Aged; Anemia, Hemolytic, Autoimmune; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bridged Bicyclo Compounds, Heterocyclic; Cyclophosphamide; Doxorubicin; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Methylprednisolone; Piperidines; Prednisone; Pyrazoles; Pyrimidines; Recurrence; Rituximab; Salvage Therapy; Sulfonamides; Vincristine | 2019 |
Treatment patterns, adverse events, healthcare resource use and costs among commercially insured patients with mantle cell lymphoma in the United States.
Topics: Adenine; Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cost of Illness; Cyclophosphamide; Doxorubicin; Drug-Related Side Effects and Adverse Reactions; Female; Follow-Up Studies; Health Care Costs; Health Care Rationing; Hospitalization; Humans; Incidence; Insurance, Health; Lymphoma, Mantle-Cell; Male; Middle Aged; Piperidines; Practice Patterns, Physicians'; Prednisone; Pyrazoles; Pyrimidines; Retrospective Studies; Rituximab; Treatment Outcome; United States; Vincristine; Young Adult | 2019 |
Comparison of real-world treatment patterns in chronic lymphocytic leukemia management before and after availability of ibrutinib in the province of British Columbia, Canada.
Topics: Adenine; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; British Columbia; Chromosome Deletion; Chromosomes, Human, Pair 17; Cyclophosphamide; Disease Management; Doxorubicin; Female; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Neoplasm, Residual; Piperidines; Prednisone; Prognosis; Pyrazoles; Pyrimidines; Recurrence; Remission Induction; Retrospective Studies; Rituximab; Smith-Magenis Syndrome; Survival Analysis; Transplantation, Homologous; Treatment Outcome; Vidarabine; Vincristine | 2020 |
Chidamide combined with ibrutinib improved the prognosis of primary bone marrow diffuse large B cell lymphoma.
Topics: Adenine; Aged; Aminopyridines; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Bone Marrow; Bone Marrow Cells; China; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Piperidines; Prednisone; Prognosis; Rituximab; Transplantation, Autologous; Vincristine | 2020 |
Transformation to plasmablastic lymphoma in CLL upon ibrutinib treatment.
Topics: Adenine; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Cell Transformation, Neoplastic; Cyclophosphamide; Doxorubicin; Fatal Outcome; Humans; Immunologic Factors; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Neoplasm Recurrence, Local; Piperidines; Plasmablastic Lymphoma; Prednisone; Syndecan-1; Vincristine | 2020 |
Adverse Events and Economic Burden Among Patients Receiving Systemic Treatment for Mantle Cell Lymphoma: A Real-World Retrospective Cohort Study.
Topics: Adenine; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Chemical and Drug Induced Liver Injury; Cyclophosphamide; Doxorubicin; Female; Health Care Costs; Humans; Lymphoma, Mantle-Cell; Male; Middle Aged; Piperidines; Prednisone; Renal Insufficiency; Retrospective Studies; Rituximab; Stroke; Vincristine | 2021 |
Real-world treatment patterns and outcomes in a national study of veterans with Waldenström macroglobulinemia, 2006-2019.
Topics: Adenine; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Bortezomib; Chlorambucil; Cyclophosphamide; Dexamethasone; Doxorubicin; Humans; Kaplan-Meier Estimate; Piperidines; Prednisone; Progression-Free Survival; Proportional Hazards Models; Retrospective Studies; Rituximab; Treatment Outcome; Veterans; Vidarabine; Vincristine; Waldenstrom Macroglobulinemia | 2021 |
Plasmablastic lymphoma transformation in a patient with Waldenström macroglobulinemia treated with ibrutinib.
Topics: Adenine; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bortezomib; Clonal Evolution; Cyclophosphamide; Disease Progression; Doxorubicin; Fatal Outcome; Female; Humans; Immunoglobulin kappa-Chains; Immunoglobulin M; Lymph Nodes; Myeloid Differentiation Factor 88; Neoplasm Proteins; Piperidines; Plasmablastic Lymphoma; Prednisone; Protein Kinase Inhibitors; Vincristine; Waldenstrom Macroglobulinemia | 2021 |
Ibrutinib- and bortezomib-extended R-CHOP induction in elderly higher-risk patients newly diagnosed with diffuse large B-cell lymphoma - first analysis of toxicity and efficacy signals.
Topics: Adenine; Aged; Antineoplastic Combined Chemotherapy Protocols; Bortezomib; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, Large B-Cell, Diffuse; Neoplasm Recurrence, Local; Piperidines; Prednisone; Rituximab; Vincristine | 2022 |
Effect of ibrutinib with R-CHOP chemotherapy in genetic subtypes of DLBCL.
Topics: Adenine; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Piperidines; Prednisone; Rituximab; Vincristine | 2021 |
Clinical impact of ibrutinib plus R-CHOP in untreated DLBCL coexpressing BCL2 and MYC in the phase 3 PHOENIX trial.
Topics: Antibodies, Monoclonal, Murine-Derived; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, Large B-Cell, Diffuse; Prednisone; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins c-myc; Rituximab; Vincristine | 2023 |
Pure red cell aplasia occurring during ibrutinib therapy for chronic lymphocytic leukemia.
Topics: Aged; Cyclosporine; Female; Humans; Immunoglobulins, Intravenous; Leukemia, Lymphocytic, Chronic, B-Cell; Prednisone; Red-Cell Aplasia, Pure; Thrombocytopenia | 2023 |